Gennova to finish Phase 2 & 3 trials of its mRNA jab by January 2022

The Phase-2 study will be conducted in 400 healthy subjects while Phase III part of the study will enroll 4000 healthy subjects who are 18 years and above upto 80 years.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3ENyoq0